SCHEMBL23891978

SCHEMBL23891978

Cn1nc2[nH]ccc2c1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 3/20 0.42
AXL P30530 2/20 0.42
CSNK1D P48730 2/20 0.35
MAPK14 Q16539 2/20 0.35
MAPK11 Q15759 1/20 0.35
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
AURKA O14965 1/20 0.34
AURKB Q96GD4 1/20 0.34
INCENP Q9NQS7 1/20 0.34
TPX2 Q9ULW0 1/20 0.34
HRH4 Q9H3N8 1/20 0.34
TTBK1 Q5TCY1 2/20 0.33
TTBK2 Q6IQ55 2/20 0.33
SIRT2 Q8IXJ6 1/20 0.33
JAK3 P52333 2/20 0.33
FGFR1 P11362 1/20 0.32
FGFR2 P21802 1/20 0.32
FGFR3 P22607 1/20 0.32
KDR P35968 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL811103 0.65 ADORA2A (0.47) CSNK1DMAPK14MAPK11ADORA2AADORA1
SCHEMBL28523368 0.63 ADORA2A (0.45) PRKCIAXLADORA2AADORA1HRH4
SCHEMBL15069153 0.63 BRD4 (0.51)
SCHEMBL13067164 0.63 ESR2 (0.49)
SCHEMBL3124523 0.60 PRKCI (0.46) PRKCIAXLADORA2AADORA1AURKB
SCHEMBL1016847 0.60 DYRK1A (0.46) PRKCIAXLADORA2AADORA1HRH4
SCHEMBL12574854 0.60 PRKCI (0.46) PRKCIAXLADORA2AADORA1TTBK1
SCHEMBL12561934 0.59 PRKCI (1.00) PRKCIAXLCSNK1DMAPK14ADORA2A
SCHEMBL20651528 0.59 AXL (0.49) PRKCIAXLADORA2AADORA1AURKA
SCHEMBL2809172 0.59 ADORA2A (0.53) PRKCIAXLADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3177611-B1 OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES NUEVOLUTION AS (DK) 2021-10-06 EP disclosed